Program News
News and stories about members of the UNC Lineberger Immunology Research Program
-
UNC researchers unlock new way to help fight skin cancer
Researchers found that inhibiting a problematic protein in the body helps immunotherapies and CAR-T therapy to better fight off melanoma.
-
Ferris elected to National Academy of Medicine
Robert Ferris, MD, PhD, has been elected to the National Academy of Medicine, one of the highest honors in the fields of health and medicine.
-
Immune cell therapy for advanced head and neck cancer helps stabilize disease
Robert Ferris, MD, PhD, and colleagues report that a single administration of autologous tumor-infiltrating lymphocyte cell therapy helped stabilize metastatic head and neck squamous cell carcinoma in some patients.
-
Uniquely engineered KRAS-targeted cancer drug found to be effective in early studies
Chad Pecot, MD, and colleagues have demonstrated that a uniquely engineered drug that zeroes in on a mutated gene called KRAS G12V could potentially stop KRAS-dependent cancers in their tracks.
-
Brent Hanks, MD, PhD, aims to advance cancer immunotherapy in the lab and clinic
Hanks has joined the UNC Lineberger Comprehensive Cancer Center, the UNC School of Medicine and UNC Health as an associate professor of medicine.
-
Combination immunotherapy before surgery may increase survival in people with head and neck cancer
Robert Ferris, MD, PhD, and colleagues report in Cancer Cell that head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy drug.
-
Three drug cocktail shows potential to boost CAR-T cancer therapy
Gianpietro Dotti, MD, and colleagues report in Nature Immunology they have identified a cocktail of three different drugs that can be used to generate more robust CAR-Ts to fight cancer.
-
UNC Lineberger members recognized for highly cited research
Nine UNC Lineberger members wrote some of the most influential scientific papers in the past decade, according to an independent analysis of research publications.
-
UNC Lineberger shines at Carolina Hurricanes’ Hockey Fights Cancer game
H.J. Kim, MD, was honored as the Hero of the Game and Robert Ferris, MD, PhD, sounded the hurricane warning siren.
-
Miller awarded V Scholar grant to investigate approaches to boost an immune response to cancer
Brian C. Miller, MD, PhD, was named a 2024 V Foundation V Scholar. The honor will support his research focused on making cancer immunotherapy more effective.
-
Milner awarded $2.79 million NIH grant to study epigenetic regulation of T cell exhaustion
The NIH has awarded a five-year, $2.79 million R01 research grant to Justin Milner, PhD, to define how a druggable family of epigenetic regulators control T cell activity.
-
Harnessing natural killer T-cells to advance cancer immunotherapy for solid tumors
Gianpietro Dotti, MD, and Xin Zhou, PhD, report in Nature Cancer that a novel immunotherapy approach utilizing natural killer T (NKT) cells produced significant antitumor activity in solid tumors.
-
Serody and Yeh honored with Battle Distinguished Cancer Research Award
Jonathan Serody, MD, and Jen Jen Yeh, MD, were named the 2023 recipients of the Hyman L. Battle Distinguished Cancer Research Award, recognizing their significant scientific achievements.
-
Investing in named professorships to attract and retain world-class faculty
Barbara Savoldo, MD, PhD, and Stephanie Wheeler, PhD, MPH, were recently approved as named distinguished professors, one of the highest honors a university bestows to a faculty member.
-
Immune cell transformation can influence stem cell transplant success in cancer patients
Jonathan Serody, MD, Ian Davis, MD, PhD, and colleagues report ILC2s can change functions after a patient receives stem cells, thereby preventing a healthy rebuilding of the immune system.